OTC:INTI | News — Page 3 | Inhibitor Therapeutics, Inc.

INTI News — Page 3

Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.

DateTypePublisherHeadlineSummary
1999-05-19Current reportSEC filingInhibitor Therapeutics, Inc. filed Form 8-KInhibitor Therapeutics, Inc. filed Form 8-K covering items 5,7.
1999-03-22Current reportSEC filingInhibitor Therapeutics, Inc. filed Form 8-KInhibitor Therapeutics, Inc. filed Form 8-K covering items 5.
1998-11-17Current reportSEC filingInhibitor Therapeutics, Inc. filed Form 8-KInhibitor Therapeutics, Inc. filed Form 8-K covering items 7.
1998-08-26Current reportSEC filingInhibitor Therapeutics, Inc. filed Form 8-KInhibitor Therapeutics, Inc. filed Form 8-K covering items 5.
1998-05-08Current reportSEC filingInhibitor Therapeutics, Inc. filed Form 8-KInhibitor Therapeutics, Inc. filed Form 8-K covering items 5,7.
1998-04-06Current reportSEC filingInhibitor Therapeutics, Inc. filed Form 8-KInhibitor Therapeutics, Inc. filed Form 8-K covering items 5,7.
1998-03-12Current reportSEC filingInhibitor Therapeutics, Inc. filed Form 8-K/AInhibitor Therapeutics, Inc. filed Form 8-K/A covering items 4,7.
1998-03-02Current reportSEC filingInhibitor Therapeutics, Inc. filed Form 8-KInhibitor Therapeutics, Inc. filed Form 8-K covering items 4,7.
1998-02-13Current reportSEC filingInhibitor Therapeutics, Inc. filed Form 8-KInhibitor Therapeutics, Inc. filed Form 8-K covering items 5,7.
1997-12-23Current reportSEC filingInhibitor Therapeutics, Inc. filed Form 8-KInhibitor Therapeutics, Inc. filed Form 8-K covering items 5,7.